Head to Head Analysis: Sintx Technologies (NASDAQ:SINT) and LivaNova (NASDAQ:LIVN)

Sintx Technologies (NASDAQ:SINTGet Free Report) and LivaNova (NASDAQ:LIVNGet Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Sintx Technologies and LivaNova, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies 1 0 1 0 2.00
LivaNova 1 2 5 0 2.50

Sintx Technologies presently has a consensus price target of $16.00, suggesting a potential upside of 358.45%. LivaNova has a consensus price target of $63.14, suggesting a potential upside of 0.13%. Given Sintx Technologies’ higher probable upside, analysts plainly believe Sintx Technologies is more favorable than LivaNova.

Risk & Volatility

Sintx Technologies has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.

Valuation and Earnings

This table compares Sintx Technologies and LivaNova”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sintx Technologies $733,000.00 17.54 -$11.02 million ($5.66) -0.62
LivaNova $1.35 billion 2.55 $63.23 million ($4.00) -15.77

LivaNova has higher revenue and earnings than Sintx Technologies. LivaNova is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Sintx Technologies and LivaNova’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sintx Technologies -775.12% -218.25% -95.06%
LivaNova -16.12% 15.98% 7.31%

Insider & Institutional Ownership

18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

LivaNova beats Sintx Technologies on 10 of the 14 factors compared between the two stocks.

About Sintx Technologies

(Get Free Report)

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

About LivaNova

(Get Free Report)

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.